GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: StockDung	6/30/2009 11:58:14 AM
	Read Replies (1) of 5582

And the line gets longer... "Federman & Sherwood Announces Investigation of Matrixx Initiatives, Inc. for Possible Securities Laws Violations OKLAHOMA CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Federman & Sherwood, an Oklahoma-based law firm specializing in securities and consumer litigation, has launched an investigation into possible securities fraud by Matrixx Initiatives, Inc. (Nasdaq:MTXX). Although the company has recalled its Zicam nasal products, the company has been investigated by the SEC with respect to its marketing practices, and it is believed that information surrounding the Zicam line of products, as well as the Company's liability in connection with these products, was not reaching the Company's shareholders. If you are a shareholder or former employee of Matrixx Initiatives and you have information that would assist our firm in its ongoing investigation, or if you have other questions relating to a loss you may have suffered in your investment, please contact William B. Federman at wbf@federmanlaw.com or (405) 235-1560.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next